Literature DB >> 6705543

Mechanisms producing hypoxemia during hemodialysis.

E J Quebbeman, W J Maierhofer, W F Piering.   

Abstract

Arterial hypoxemia occurs frequently during hemodialysis. Proposed mechanisms for this phenomenon have included hypoventilation and embolism of granulocyte aggregates. We studied 18 patients with endstage renal failure who required chronic hemodialysis, and measured arterial blood gases, pulmonary gas exchange, and dialyzer gas exchange. During use of acetate as a dialysate buffer, PaO2 decreased to 80 +/- 6.8 torr, whereas during use of the bicarbonate buffer oxygen tension remained at 92 +/- 4.9 torr or greater. Hypoventilation and microembolism were not sufficient to explain the degree of hypoxemia during acetate dialysis. Hypoxemia occurred only after the 1st exposure to acetate; neither an instantaneous change to bicarbonate nor stopping dialysis restored oxygen tension to normal. We conclude that a pharmacologic action of acetate adversely affects lung function, aggravating the decreased alveolar oxygen tension (PAO2) due to hypoventilation. Hypoxemia was not present when bicarbonate was used. Acetate buffer should not be used for dialysis in patients with unstable cardiovascular or respiratory systems.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6705543     DOI: 10.1097/00003246-198404000-00004

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  4 in total

1.  [Modification of gas exchange and metabolism by various hemodialysis procedures].

Authors:  S Grosser; G Kreymann; S Meierling; W Daerr; A Raedler; H Greten
Journal:  Klin Wochenschr       Date:  1990-08-17

Review 2.  Extracorporeal treatment of acute renal failure in the intensive care unit: a critical view.

Authors:  M Schetz; P M Lauwers; P Ferdinande
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

3.  Plasma acetate, gluconate and interleukin-6 profiles during and after cardiopulmonary bypass: a comparison of Plasma-Lyte 148 with a bicarbonate-balanced solution.

Authors:  Paul G Davies; Balasubramanian Venkatesh; Thomas J Morgan; Jeffrey J Presneill; Peter S Kruger; Bronwyn J Thomas; Michael S Roberts; Julie Mundy
Journal:  Crit Care       Date:  2011-01-14       Impact factor: 9.097

4.  Plasma-Lyte 148: A clinical review.

Authors:  Laurence Weinberg; Neil Collins; Kiara Van Mourik; Chong Tan; Rinaldo Bellomo
Journal:  World J Crit Care Med       Date:  2016-11-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.